Management of peripheral arterial disease

Diabetes Spectrum

Volumn 21, Issue 3, 2008, Pages 171-176

  Steffen, Lyn M ^a   Duprez, Daniel A ^b   Boucher, Jackie L ^c   Ershow, Abby G ^d   Hirsch, Alan T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; CARDIOVASCULAR AGENT; CILOSTAZOL; CLOPIDOGREL; FLAVONOID; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOUNSATURATED FATTY ACID; OLIVE OIL; POLYUNSATURATED FATTY ACID; RAPESEED OIL; TERPENE DERIVATIVE; TRANS FATTY ACID; VEGETABLE OIL;

ANKLE BRACHIAL INDEX; ARTERIAL PRESSURE; ARTERY BLOOD FLOW; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET THERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DYSLIPIDEMIA; ECHOGRAPHY; ENDOVASCULAR SURGERY; EXERCISE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; LEG AMPUTATION; LEG BLOOD FLOW; LEG REVASCULARIZATION; LIFESTYLE MODIFICATION; MICROANGIOPATHY; MORBIDITY; MORTALITY; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SYMPTOM; SYSTOLIC BLOOD PRESSURE;

EID: 52649123798     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.21.3.171     Document Type: Article

References (54)

1. Hirsch AT, Hartman L, Town RJ, Virnig BA: National healthcare costs of peripheral arterial disease in the USA Medicare population. Vasc Med In press
2. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WRC, Olin JW, Puschett JB, Kenneth A, Rosenfield, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA: ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation 113:1474-547, 2006
3. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern M, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Stemberger J, Thom T, Wilson M, Hong Y: Heart disease and stroke statistics - 2008 update: a report form the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25-e146, 2008
4. Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease inpatients with diabetes attending a hospital clinic. Pract Diabetes Int 16:153-166, 1999
5. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286:1317-1324, 2001
6. Beks PJ, Mackaay AJ, de Neeling JN, de Bries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 38:86-96, 1995
7. Marso S, Hiatt WR: Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 47:921-929, 2006
8. Allison MA, Criqui MH, McClelland RL, Scott JM, McDermott MM, Liu K, Folsom AR, Bertom AG, Sharrett AR, Homma S, Kori S: The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 48:1190-1197, 2006
9. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP:. Prevelence of peridpheral arterial disease and risk factors in persons aged 60 and older: Data from the National Health and Nutrition Examination Survey 1999-2004. J Am Eriart Soc 55:583-589, 2007
10. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D: The prevalence of peripheral arterial disease in a defined population. Circulation 71:510-515, 1985
11. Heald CL, Fowkes FG, Murray GD, Price JF, Ankle Brachial Index Collaboration: Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 189:61-69, 2006
12. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, McDermott MM, Hirsch AT: The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program. Vasc Med 13:15-24, 2008
13. Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G, McDermott MM: Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25:113-120, 2002
14. Adler AI, Boyko EJ, Ahroni JH, Smith DG: Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care, 22:1029-1035, 1999
15. Bird CE, Criqui MH, Fronek A, Denenberg JO, Klauber MR, Langer RD: Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4:15-21, 1999
16. Wrobel JS, Mayfield JA, Reiber GE; Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care 24:860-864, 2001
17. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentrations of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428, 1998
18. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E: Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109: 3196-3201, 2004
19. American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care 26:3333-3341, 2003
20. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Gota S, Liau CS Richard AJ, Rother J, Wilson PWF for the REACH Registry Investigators: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295:180-189, 2006
21. Steg G, Bhatt DL, Wilson PWF, D'Agostino R, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S, for the REACH Registry Investigators: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297:1197-1206, 2007
22. Selvin E, Hirsch AT: Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis 2008 [Epub ahead of print. doi:10.1016/ j. atherosclerosis.2008.02.002]
23. Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood EM, Mohler ER, Creager MA, Hobson RW, Robertson RM, Howard WJ, Schroeder P, Criqui MH for the Peripheral Arterial Disease Coalition: Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation 116:2086-2094, 2007
24. Hankey GJ, Norman PE, Eikelboom JW: Medical treatment of peripheral arterial disease. JAMA 295:547-S53, 2006
25. Milani RV, Lavie CJ: The role of exercise training in peripheral arterial disease. Vasc Med 12: 351-358, 2007
26. Leng GC, Fowler B, Ernst E: Exercise for intermittent claudication [Review]. Cochrane Database Syst Revs Issue 2. Art. No.: CD000990, 2000
27. Garg PK, Tian L, Criqui MH, Liu K, Ferrucci L, Gulalnik JM, Tan J, McDermott MM: Physical activity during daily life and mortality in patients with peripheral artery disease. Circulation 114:242-248, 2006
28. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT: Exercise training for claudication. N Engl J Med 347:1941-1951, 2002
29. Antonelli-Incalzi R, Pedone C, McDermott MM, Bandinelli S, Miniati B, Lova RM, Lauretani F, Ferrucci L: Association between nutrient intake and peripheral artery disease: results from the InCHIANTI study. Atherosclerosis 186:200-206, 2006
30. Leng GC, Taylor GS, Lee AJ, Fowkes FGR, Horrobin D: Essential fatty acids and cardiovascular disease: the Edinburgh Artery Study. Vasc Med 4: 219-226, 1999
31. Arts IC, Hollman PC: Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81(Suppl):317S-325S, 2005
32. Munteanu A, Zingg JM, Azzi A: Antiatherosclerotic effects of Vitamin E: myth or reality? J Cell Mol Med 8:59-76, 2004
33. Leng GC, Fowkes FGR, Smith FB, Lowe GDO, Donnan PT, Ells K: Plasma essential fatty acids, cigarette smoking and dietary antioxidants in peripheral artery disease: a population-based case-control study. Arterioscler Thromb 14: 471-478, 1994
34. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL: Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103:1863-1868, 2001
35. Ciccarone E, Di Castelnuovo A, Salcuni M, Siani A, Giacco A, Donati MB, De Gaetano G, Capani F, Iacoviello L, on behalf of the Gendiabe Investigators: A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes. J Thromb Haemost 1:1744-1752, 2003
36. Mitrou PN, Kipnis V, Thiebaut AC, Reedy J, Subar AF, Wirfalt E, Flood A, Mouw T, Hollenbeck AR, Leitzmann MF, Schatzkin A: Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 167:2461-2468, 2007
37. Panagiotakos DB, Tzima N, Pitsavos C, Chrysohoou C, Zampelas A, Toussoulis D, Stefanadis C: The association between adherence to the Mediterranean diet and fasting indices of glucose homoeostasis: the ATTICA Study. J Am Coll Nutr 26:32-38, 2007
38. American Dietetic Association: Type 1 and type 2 diabetes evidence-based nutrition practice guidelines for adults [article online]. Available from http://www.adaevidencelibrary.com/topic.cfm?=3252
39. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH. Karanja N, of the DASH Collaborative Research Group: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117-1124, 1997
40. Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, Gross MD, Jacobs DR Jr: Associations of plant food, dairy product, and meat intake with 15-y incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 82:1169-1177, 2005
41. Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Makagawa H: Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: The Chicago Western Electric Study. Am J Epidemiol 159:572-580, 2004
42. Djousse L, Levy D, Lurabito JM, Cupples LA, Ellison RC: Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study. Circulation 102:3092-3097, 2000
43. Rimm EB, Moats C: Alcohol and coronary heart disease: drinking patterns and mediators of effect. Ann Epidemiol 17:S3-S7, 2007
44. Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, Kakafika AI, Karagiannis A, Lambropoulos S, Elisaf M: Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology 58:689-697, 2008
45. Booyse FM, Pan W, Grenett HE, Parks DA, Darley-Usmar VM, Bradley KM, Tabengwa EM: Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Ann Epidemiol 17:S24-S31, 2007
46. U.S. Department of Health and Human Services and U.S. Department of Agriculture: Dietary Guidelines for Americans, 6th ed. Washington, D.C.. U.S. Government Printing Office, 2005
47. American Diabetes Association: Nutrition recommendations and interventions for diabetes [Position Statement]. Diabetes Care 31 (Suppl. 1):S61-S78, 2008
48. Steffen LM, Folsom AR, Cushman M, Jacobs DR Jr, Rosamond WD: Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism. Circulation 115:188-195, 2007
49. Haven J, Burns A, Herring D, Britten P: MyPryamid.gov provides consumers with practical nutrition information at their fingertips. J Nutr Educ Behav 38:S1S3-S154, 2006
50. Duprez DA, De Buyzere ML, Hirsch AT: Developing pharmaceutical treatments for peripheral artery disease. Expert Opin Invest Drugs 12:101-108, 2003
51. Warfarin Antiplatelet Vascular Evaluation Trial investigators: Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357:217-227, 2007
52. Clement DL, De Buyzere ML, Duprez DA: Hypertension in peripheral arterial disease. Curr Pharm Des 10:3615-3620, 2004
53. Hirsch AT, Duprez D: The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease. Vasc Med 8:273-278, 2003
54. Duprez DA: Pharmacological interventions for peripheral artery disease. Expert Opin Pharmacother 8:1-12, 2007